Bio
Seema received her PhD degree in vascular pharmacology from Duesseldorf, Germany in 2010 with the best doctoral thesis award. During her postdoctoral training in ?bed to bench side translational research? with focus on non-coding RNA epigenetics of cardiovascular disease progression and novel biomarkers screening in Prof. Thomas Thum?s lab in Germany, she received European Foundation (EFSD) grant and DHD fellowship to study platelet miRNA mediated vascular cell cross talk in diabetes. Later in 2014, she secured German Research foundation (DFG) independent PI grant to investigate epigenetic mechanisms of impaired tissue repair in diabetes, initiated a collaboration between German and USA labs and worked on epigenetic mechanisms in Prof. Aristidis Veves? lab at BIDMC and Prof. Liao?s Lab at Brigham & Woman?s Hospital. In September 2018, she joined Stanford School of Medicine as an Instructor. Her major research interests are non-coding RNAs driven mechanisms underlying cellular cross talks and tissue tropism during progression of cardiac amyloidosis, diabetes associated complications.
Professional Education
-
Postdoc Fellow, BIDMC, Harvard Medical School and Medical School Hannover, Epigenetics of Diabetic wound healing (2017)
-
Postdoc Fellow, Medical School Hannover, Germany, Translational epigenetics and molecular therapeutics of CVD and diabetic vascular complications (2014)
-
PhD, Heinrich Heine University, Duesseldorf, Germany, Vascular Pharmacology and molecular biology (2010)
-
MPharm, M.S.University Vadodara, Gujrat, India, Experimental and clinical Pharmacology (2005)
-
BPharm, Hemwati Nandan Bahuguna Garhwal University, Srinagar, Uttarakhand, India, Pharmacy (2003)